Denmark Bars Johnson & Johnson Vaccine From Covid Vaccination Programme

The Danish Health Authority noted that the European Medicines Agency (EMA) "has concluded that there is a possible link between rare but severe cases of blood clots" and the Johnson & Johnson drug.

Denmark said Monday it will bar the Johnson & Johnson vaccine from its Covid inoculation drive over worries about blood clots, following a similar move against the AstraZeneca jab. The Danish Health Authority noted that the European Medicines Agency (EMA) "has concluded that there is a possible link between rare but severe cases of blood clots" and the Johnson & Johnson drug. Both the EMA and the World Health Organization have however recommmended the use of the Johnson & Johnson vaccine on the basis that the benefits outweigh the risks. But Danish health officials said the current favourable epidemiological situation in the Scandinavian country meant it could do without the J&J jab, and would rely only on the Pfizer/BioNTech and Moderna vaccines.